The Projected Growth of Digital Biomarkers Market to $17.73 Billion by 2031

The Projected Growth of Digital Biomarkers Market to $17.73 Billion by 2031



The digital biomarkers market is set to experience considerable expansion, with estimates suggesting growth from approximately $7.41 billion in 2026 to $17.73 billion by 2031. This represents a robust compound annual growth rate (CAGR) of 19.1%, indicating a significant transformation in how clinical research incorporates technology.

1. Overview of Digital Biomarkers Market


Digital biomarkers are indicators of health and disease that are collected and assessed using digital tools. Their integration into clinical research is pivotal for ensuring more precise and continuous monitoring of patients' health. With the rise of over 30,000 clinical trials initiated annually, the demand for effective monitoring solutions has surged, emphasizing the necessity for digital biomarkers.

1.1 Factors Driving Growth


Several factors contribute to the rapid growth of this market. Primarily, the transition towards data-driven clinical research models highlights the increasing reliance on large datasets gathered from wearables and mobile devices. These innovative technologies allow researchers to monitor physiological functions in real time, resulting in better treatment efficacy assessments.

1.2 Key Segments in the Market


  • - By Type: The physiological biomarkers segment led the market with 40.6% share in 2025, reflecting the demand for continuous health tracking through devices that monitor heart rate, activity levels, and other vital functions.
  • - By Therapeutic Area: The cardiovascular segment holds the largest share, underlining the ongoing battle against heart diseases, which claim approximately 17.9 million lives each year globally. The extensive research focused on this area leads to a greater need for constant monitoring through digital solutions.
  • - By Region: North America dominates the digital biomarkers market, capturing 48.1% of the share in 2025. The region's leadership is attributed to its advanced clinical research landscape, supported by cutting-edge digital health technologies.

2. The Role of Technology in Clinical Trials


The surge in clinical trials leveraging digital biomarkers is notable. By adopting digital endpoints and automated monitoring solutions, researchers can capture real-world patient data efficiently, leading to enhanced operational efficiencies.

2.1 Increasing Adoption of Digital Solutions


More than half of the participants in clinical trials have integrated remote data capture strategies in their studies, with an increasing number of studies utilizing digital biomarkers. Therapeutic areas like cardiology, neurology, endocrinology, and psychiatry are at the forefront of adopting these technologies, ensuring that patient monitoring is more precise and timely.

2.2 Revolutionizing Clinical Research


The shift towards decentralized clinical trials is revolutionizing how health data is collected and analyzed. Better data collection methods allow early-phase trials to incorporate high-frequency data measurement, thus enhancing the quality of research findings.

3. The Importance of Continuous Monitoring


With the rising prevalence of chronic diseases, continuous health monitoring facilitated by wearable technologies is becoming essential. This is evident in the growing acceptance of digital monitoring among healthcare professionals and researchers.

4. Leading Companies in Digital Biomarkers


Several companies are shaping the future of the digital biomarkers market, including:
  • - IXICO PLC (UK)
  • - AliveCor, Inc. (US)
  • - Empatica, Inc. (US)
  • - CONNEQT Health (US)
These organizations are pioneering advancements in digital health solutions, focusing on enhancing patient engagement and delivering actionable health insights.

5. Conclusion


The digital biomarkers market holds immense potential, not only in advancing clinical research and improving patient outcomes but also in making significant strides towards healthcare delivery innovation. As we move towards 2031, the expectation is clear: digital biomarkers will play a central role in reshaping the landscape of healthcare monitoring and research methodologies.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.